NEUP CIK: 1191070

Neuphoria Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY26
FY23 – FY26
(positive)
Change from FY23 to FY26
millions USD
FY23:
−14.6
FY24:
−14.7
FY25:
0.08
FY26:
−12.4
Change from FY23 to FY26
millions USD
FY23:
3.86
FY24:
15.1
FY25:
1.53
FY26:
17.9
millions USD
FY23:
–
FY24:
0.50
FY25:
1.60
FY26:
5.58

All amounts in millions USD Data source:SEC EDGAR